RECRUITING

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Talk to us

Conditions

Chronic Obstructive Pulmonary DiseaseCOPDPulmonary RehabilitationTelehealth

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.

Official Title

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)

Quick Facts

Study Start:2022-06-28
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05119556

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 40 or greater
  2. 2. Clinical diagnosis of COPD
  3. 3. Hospitalized for acute exacerbation of COPD.
  4. 4. Be willing to adhere to trial and follow-up procedures and give informed consent
  1. 1. Secondary diagnosis of congestive heart failure that is severe as documented by active symptoms, New York Heart Association (NYHA) functional classification IV or left ventricular ejection fraction \<25% on echocardiography
  2. 2. Other respiratory conditions that could confound the diagnosis such as asthma, pulmonary fibrosis, bronchiectasis, and lung cancer. Participants with pneumonic exacerbations of COPD will be included.
  3. 3. Primary diagnosis of COVID pneumonia. Individuals with incidentally detected COVID or persistently positive for COVID but deemed to be convalescent will not be excluded.
  4. 4. Active cancers on chemotherapy or radiation therapy
  5. 5. Immunosuppressed states predisposing to frequent hospitalizations including uncontrolled HIV/AIDS
  6. 6. Active or recent (within 1 month) myocardial infarction
  7. 7. Angina not well-controlled by medication
  8. 8. Unstable cardiac arrhythmias, atrial or ventricular
  9. 9. Supplemental oxygen requirement greater than 5 liters per minute at either rest or with exertion
  10. 10. Significant cognitive dysfunction, including dementia, that in opinion of investigator would impair ability to safely or effectively engage in study protocol
  11. 11. Participants with any terminal medical illnesses as diagnosed by a physician, and/or on hospice
  12. 12. Currently enrolled in and participating in pulmonary rehabilitation
  13. 13. Treatment with chronic or newly initiated home ventilatory support. Those on in-patient short-term non-invasive ventilation will not be excluded.
  14. 14. Special patient groups such as prisoners and institutionalized patients
  15. 15. Participants with musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program
  16. 16. Current participation in any other interventional clinical trial
  17. 17. Inability to understand and speak English during exercise sessions
  18. 18. Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol

Contacts and Locations

Study Contact

Surya P Bhatt, MD, MSPH
CONTACT
205-934-5555
sbhatt@uabmc.edu
Elizabeth Plan
CONTACT
205-934-5555
epkennedy@uabmc.edu

Principal Investigator

Surya P Bhatt, MD, MSPH
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35233
United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611
United States
University of Iowa
Iowa City, Iowa, 52242
United States
Johns Hopkins University
Baltimore, Maryland, 21287
United States
University of Maryland
College Park, Maryland, 20742
United States
Boston VA Hospital
Boston, Massachusetts, 02130
United States
HealthPartners Institute
Bloomington, Minnesota, 55440
United States
Minnesota VA HealthCare System
Minneapolis, Minnesota, 55455
United States
Northern Westchester Hospital/Northwell Health
Chappaqua, New York, 10514
United States
Cincinnati VA Hospital
Cincinnati, Ohio, 45220
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
Temple University Hospital
Philadelphia, Pennsylvania, 19122
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260
United States
Baylor College of Medicine
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Surya P Bhatt, MD, MSPH, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-28
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2022-06-28
Study Completion Date2027-08-31

Terms related to this study

Keywords Provided by Researchers

  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Pulmonary Rehabilitation
  • Telehealth

Additional Relevant MeSH Terms

  • Chronic Obstructive Pulmonary Disease